Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $51M
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 08.06.2023 | Series A | $51M | - | socaltech.... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 08.06.2023 | Kate Therapeutics comes out of stealth with a $51M Series A ... | - | connect.or... |
| 08.06.2023 | Kate Therapeutics Raises $51M | San Diego-based Kate Therapeutics has raised $51M in a Series A funding round, the company announced... | socaltech.... |
| 08.06.2023 | Kate Therapeutics Raises $51M in Series A Funding | Kate Therapeutics, a San Diego, CA-based gene therapy company, raised $51M in Series A funding. The... | finsmes.co... |
| - | Kate Therapeutics | “Kate Therapeutics” | fastfounde... |
| - | Kate Therapeutics: Gene Therapy Company Raises $51 Million | Kate Therapeutics – a next-generation gene therapy company – recently emerged from stealth mode with... | pulse2.com... |